Cairn Diagnostics

Cairn Diagnostics is a specialized, innovative life sciences company focused on developing novel breath tests intended for routine use in diagnostic medicine. At Cairn Diagnostics, our mission is to develop tests that eliminate complexity and create a safer, faster, and clearer path to diagnosis. Cairn manufactures tests that are labeled with a safe, non-radioactive stable isotope of carbon, carbon-13 (13C), and serves community-based practices and partners with university-based researchers, medical device, and pharmaceutical companies. Cairn Diagnostics has developed the 13C-Spirulina Gastric Emptying Breath Test (GEBT) as an aid in the diagnosis of delayed gastric emptying (gastroparesis) in adults. Gastroparesis is...

Gastroenterology,non-radioactive isotope 13c,spirulina,fda approved,breath testing,gastroparesis,standardized,non-invasive,gas isotope ratio mass spec (girms) instrumentation,bariatrics,diabetes,solid phase gastric emptying,delayed gastric emptying,class iii medical device,telehealth,and medicare coverage

Cairn diagnostics operates in the Medical equipment manufacturing industry.

Cairn diagnostics's revenue is 11m - 100m

Cairn diagnostics has 11 - 50 employees.